The utilization of the multimodal immunotherapy for the opsoclonus–myoclonus syndrome can reduce relapses and permanent neurological sequelae

The utilization of the multimodal immunotherapy for the opsoclonus–myoclonus syndrome can reduce relapses and permanent neurological sequelae

Abstract Background There is no known effective treatment strategy to prevent relapses and avert permanent neurological sequelae in opsoclonus–myoclonus syndrome (OMS). To describe the treatment strategy that reduced relapses and led to remission of OMS without permanent neurological sequelae. Metho...

Full description

Saved in:
Bibliographic Details
Main Authors: Fang He, Miriam Kessi, Ciliu Zhang, Jing Peng, Fei Yin, Lifen Yang
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Italian Journal of Pediatrics
Subjects:
Opsoclonus–Myoclonus syndrome
Multimodal therapy
Intravenous dexamethasone
Rituximab
Intravenous immunoglobulin
Relapses
Online Access:https://doi.org/10.1186/s13052-025-01875-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13052-025-01875-2

Similar Items